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Abstract
Background:  The identification of the adipocyte-derived obesity gene product, leptin (Ob), and
subsequently its association with reproduction in rodents and humans led to speculations that leptin may
be involved in the regulation of oocyte and preimplantation embryo development. In mice and pigs, in vitro
leptin addition significantly increased meiotic resumption and promoted preimplantation embryo
development in a dose-dependent manner. This study was conducted to determine whether leptin
supplementation during in vitro maturation (IVM) to horse oocytes could have effects on their
developmental capacity after fertilization by IntraCytoplasmic Sperm Injection (ICSI).
Methods: Compact and expanded-cumulus horse oocytes were matured in medium containing different
concentrations (1, 10, 100, 1000 ng/ml) of recombinant human leptin and the effects on maturation,
fertilization and embryo cleavage were evaluated. Furthermore, early developmental expression of Ob and
leptin receptor (Ob-R) was investigated by immunocytochemical staining.
Results: In expanded-cumulus oocytes, the addition of leptin in IVM medium improved maturation (74%
vs 44%, for 100 ng/ml leptin-treated and control groups, respectively; P < 0.05) and fertilization after ICSI
(56% vs 23% for 10 ng/ml leptin-treated and control groups, respectively; P < 0.05). However, the
developmental rate and quality of 8-cell stage embryos derived from leptin-treated oocytes (100 ng/ml)
was significantly reduced, in contrast to previous data in other species where leptin increased embryo
cleavage. Ob and Ob-R proteins were detected up to the 8-cell stage with cortical and cytoplasmic
granule-like distribution pattern in each blastomere.
Conclusion: Leptin plays a cumulus cell-mediated role in the regulation of oocyte maturation in the mare.
Species-specific differences may exist in oocyte sensitivity to leptin.
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Background
Leptin, the product of the obesity (Ob) gene [1], predom-
inantly synthesized by adipocytes, has been shown to be
involved in the regulation of the reproductive function [2]
and recent studies have been performed, by exploiting the
potential role of this hormone in animal models, such as
mouse, swine and bovine, to evaluate the possibility of
improving in vitro oocyte maturation and embryo culture
procedures. In the mouse, Kawamura et al. [3,4] demon-
strated that leptin supplementation in the culture
medium (10, 100 and 1000 ng/ml) promoted embryo
development and increased the cell numbers of cultured
blastocysts and the effect was preferentially observed in
the trophoectoderm. These findings raised the possibility
that leptin might regulate mouse preimplantation embryo
development through a paracrine pathway. In pigs, leptin
addition in oocyte maturation medium (10 and 100 ng/
ml) significantly increased the proportion of oocytes
reaching the metaphase II (MII) stage, elevated ooplasmic
cyclin B1 protein content and enhanced embryo develop-
mental potential, thus suggesting that leptin might play a
role in both nuclear and cytoplasmic maturation [5]. Dur-
ing porcine oocyte maturation, leptin increased phospho-
rylated mitogen-activated protein kinase (MAPK) content
by 2.8-fold, and leptin-stimulated oocyte maturation was
blocked when leptin-induced MAPK phosphorylation was
suppressed by a specific MAPK activation inhibitor,
U0126, demonstrating that leptin enhanced nuclear mat-
uration via activation of the MAPK pathway [5]. Kun et al.
[6] confirmed that 10 and 100 ng/ml of leptin in matura-
tion medium enhanced porcine embryo development.
These authors showed that there was no effect of the tim-
ing of leptin supplementation, in maturation medium, on
meiotic maturation of porcine oocytes. In bovine, Paula-
Lopes et al. [7] showed that leptin supplementation (1
and 10 ng/ml) exerted positive effects during oocyte mat-
uration, by influencing blastocyst development, apoptotic
index in cumulus cells and transcript levels of develop-
mentally important genes. Moreover, they demonstrated a
role for cumulus cells in mediating leptin effects. These
authors hypothesized that leptin might influence the syn-
thesis and release of cumulus cell-derived factors, which
reach the oocyte through gap junction coupling and/or
the extracellular environment.
Leptin acts via transmembrane receptors, which show
structural similarity to the class I cytokine receptor family.
The leptin receptor (Ob-R) is produced in several alterna-
tively spliced forms that have in common an extracellular
domain of over 800 amino acids, a transmembrane
domain of 34 amino acids and a variable intracellular
domain, characteristic for each of the isoforms. These iso-
forms can be classified into three main classes: short (Ob-
Ra), long (Ob-Rb) and secreted [8].
In the mouse, Ryan et al. [9], using immunohistochemis-
try, observed protein expression of the long form of the
leptin receptor (Ob-Rb) in the ovary, with high intensities
observed in oocytes, thecal cells and corpora lutea with
peak expression at ovulation. In the pig, Craig et al. [5]
demonstrated that Ob-R is expressed in oocytes from all
stages of follicular development and oocyte maturation,
with the highest level of expression occurring in oocytes
from medium follicles and at GVBD, indicating that its
expression is dependent on follicular stage and oocyte
maturation.
In the horse, in vitro fertilization (IVF) has been for a long
time unsuccessful and reasons have been related to
incomplete in vitro oocyte maturation (IVM) [10], ineffi-
cient sperm capacitation [11] or changes in oocyte zona
pellucida [12,13]. In a recent study, McPartlin et al. [14]
characterized stallion sperm hyperactivation and demon-
strated that hyperactivation of capacitated sperm sup-
ported equine IVF. Intracytoplasmic sperm injection
(ICSI) has been adopted as an alternative method to con-
ventional IVF because sperm injection eliminates prob-
lems related to sperm binding and penetration but the
complexity of oocyte maturation has not yet been over-
came. ICSI is a valid tool for evaluating cleavage rates of in
vitro-matured horse oocytes and ooplasmic maturation.
Several studies reported a cleavage rate of 50-80% [15-18].
Unfortunately, only a small percentage of cleaved zygotes
goes on to form blastocysts in culture (25-35%) [19,20].
This result may reflect the poor cytoplasmic maturation of
equine oocytes matured in vitro [21]. In the literature, dif-
ferent culture media have been evaluated to improve the
rate of equine oocyte maturation, including TCM199 [22-
27], B2 [22] and Ham's F10 [28], supplemented with dif-
ferent concentrations of serum, hormones or follicular
fluid. These conditions resulted in maturation rates vary-
ing from 20 to 85% but none of these has increased the
efficiency of IVF or ICSI.
The presence of leptin and leptin receptor in equine
oocytes have been previously evidenced by an immunocy-
tochemical study in compact cumulus oocytes recovered
immediately upon collection and after in vitro maturation
(IVM) from fillies and from mares of light or heavy body
weight breeds [29]. To our knowledge, studies on the
effects of leptin in equine oocytes and embryos were not
reported to date. Since oocyte developmental competence
is best assessed by its ability to undergo embryonic devel-
opment [30], the present study investigated the effect of
leptin supplementation in IVM medium on maturation,
fertilization and development of horse oocytes after ICSI.
In addition, the developmental expression of Ob and Ob-
R proteins in early embryo development was analyzed by
immunocytochemical staining.Reproductive Biology and Endocrinology 2009, 7:113 http://www.rbej.com/content/7/1/113
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Methods
All chemicals were purchased from Sigma-Aldrich
(Milano, Italy) unless otherwise indicated.
Collection of oocytes
The study was conducted in Southern Italy (41° North
parallel). Ovaries from mares of unknown reproductive
history obtained at two local abattoirs, located at a maxi-
mum distance of 20 Km (30 min) from the laboratory,
were transported and processed for the scraping proce-
dure as previously described [31]. Cumulus-oocyte com-
plexes (COCs) were recovered from medium size follicles
(0.5 to 2.5 cm in diameter), identified in the collected
mural granulosa cells by using a dissection microscope
and only healthy COCs, classified as having an intact,
compact (Cp) or expanded (Exp) cumulus investment
[24,31] were selected for culture; degenerating oocytes
showing shrunken, dense or fragmented cytoplasm were
recorded and discarded. The time between follicle scrap-
ing and beginning of oocyte culture was less than 1 hour.
Total time between slaughter and culture ranged between
2 to 4 hours.
In vitro maturation
In vitro maturation (IVM) was performed following the
procedure described by Dell'Aquila et al., 2003 [31].
Medium TCM-199 with Earle's salts, buffered with 4.43
mM HEPES and 33.9 mM sodium bicarbonate and sup-
plemented with 0.1 g/L L-glutamine, 2 mM sodium pyru-
vate, 2.92 mM calcium-L-lactate penthahydrate (Fluka
21175 Serva Feinbiochem GmbH & Co Heidelberg, Ger-
many No.29760) and 50 μg/mL gentamicin was used.
After preparation, pH was adjusted to 7.18 and the
medium was filtered through 0.22-μm filters (No.5003-6,
Lida Manufacturing Corp., Kenosha WI, USA) and stored/
refrigerated (4°C) until use for a maximum of one week.
On the day of IVM, medium was further supplemented
with 20% (v/v) Fetal Calf Serum (FCS). Then, gonado-
trophins (10 μg/mL ovine FSH and 20 μg/mL ovine LH)
and 1 μg/mL 17β Estradiol were added. The medium was
filtered again and allowed to equilibrate for 1 hour under
5% CO2 in air before being used. Compact and expanded
COCs were washed three times in the culture medium and
groups of up to 10 COCs with the same cumulus mor-
phology were placed in 400 μL of medium/well of a four-
well dish (Nunc Intermed, Roskilde, Denmark), covered
with pre-equilibrated lightweight paraffin oil and cultured
for 28 to 30 h at 38.5°C under 5% CO2 in air. The effects
of recombinant human leptin (Sigma L-4146), added to
the culture well, were tested at the concentrations of 1, 10,
100 and 1000 ng/ml that were reported to be effective in
stimulating oocyte maturation in dose-response curve
experiments in porcine [5,6] and bovine [7] oocytes.
Oocytes cultured in the absence of leptin were used as
controls.
Oocyte preparation for ICSI
After IVM culture, oocytes underwent cumulus and
corona cells removal by incubation in TCM 199 with 20%
FCS containing 80 IU hyaluronidase/mL and aspiration in
and out of glass pipettes finely heat pulled to the diameter
of the equine oocytes. Oocyte morphology after denuding
was assessed under a Nikon SMZ 1500 stereomicroscope
(× 60-110 magnification). Those oocytes showing an
intact zona pellucida, regular-shaped perivitelline space,
1st polar body presence in the perivitelline space, intact
oolemma, regular ooplasmic shape and texture (no vacu-
oles) were classified as mature and morphologically nor-
mal [32-34] and underwent microinjection.
Semen preparation for ICSI
Fresh semen samples from a mature stallion with a repro-
ductive history of normal fertility were used and trials
were performed in the reproductive season (February to
September 2008). The stallion was located in the repro-
ductive centre Pegasus (Department of Animal Produc-
tion, University of Bari, Southern Italy) and was routinely
used in artificial insemination programs. Semen was col-
lected by using Missouri artificial vagina with an in-line
gel filter, extended with INRA 96 (IMV Technologies, Pia-
cenza, Italy) at the concentration of 20-25 × 106 sperm
cells/mL and used immediately. Sperm cells for ICSI were
prepared by the swim-up procedure in Earle's balanced
salt solution (EBSS) supplemented with 0.4% BSA, 50 μg/
mL gentamicin as previously described [31-35].
ICSI procedure
Intracytoplasmic sperm injection was carried out as previ-
ously reported [31-35]. All procedures were performed at
38.5°C in Global medium (IVFonline, Ontario, Canada).
Each injected oocyte was then transferred to a single 25 μL
drop of fresh Global medium covered by lightweight par-
affin oil and incubated at 38.5°C for 18-20 hours under
5% CO2 in air.
Embryo culture and evaluation
Injected oocytes were allowed to further develop in vitro
for 72 hours in the same medium. On each culture day,
embryonic developmental stage was recorded and
embryo quality was graded as follows: type a = blast-
omeres of equal size with <10% cytoplasm fragmentation;
b = blastomeres of equal size with 10 to 40% fragmenta-
tion; c = unequal blastomeres with 10 to 40% fragmenta-
tion; d = unequal blastomeres with >40% fragmentation.
At the end of culture time, embryos were removed from
culture, fixed and evaluated as described below. The
uncleaved ova were removed after 48 hours culture, fixed
and evaluated with the same procedures as described
below.Reproductive Biology and Endocrinology 2009, 7:113 http://www.rbej.com/content/7/1/113
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Immunocytochemistry
According to the procedures described by Kim et al. [36],
with some modifications, 2-, 4-, 8-cell stage ICSI-derived
embryos, fertilized and unfertilized oocytes were fixed for
4 hours in 3.7% paraformaldehyde at 4°C. Unless other-
wise stated, incubations were carried out at 4°C. Oocytes
and embryos were washed four times, for 20 min, in PBS
containing 1% Triton X-100 (PBS-T). First step: oocytes
and embryos were placed overnight in a blocking solution
consisting of 0.1 M glycine, 1% goat serum, 0.01% Triton
X-100, 1% powdered nonfat dry milk, 0.5% bovine serum
albumine (BSA) and 0.02% sodium azide in PBS. The Ob-
R primary antibody was raised against a recombinant pro-
tein corresponding to amino acids 541-840 mapping
within an internal domain of human Ob-R (sc-1834,
Santa Cruz Biotech Heidelberg Germany). After blocking,
oocytes and embryos were incubated overnight with the
primary antibody diluted to 1:100 in PBS-T. Second step:
oocytes and embryos were then washed four times, for a
total time of 15 min, in PBS-T and placed in the solution
containing the secondary antibody [goat anti-rabbit fluo-
rescein isothiocyanate (FITC)-conjugated antibody, Santa
Cruz Biotech, diluted 1:100 in PBS-T] for 4 h. Oocytes and
embryos were washed four times, for 15 min, in PBS-T.
The Ob primary rabbit antibody was raised against the N-
terminal region of the Ob gene product of human and to
a lesser extent, mouse and rat (sc-842; Santa Cruz Biotech.
Inc., Santa Cruz, CA). Oocytes and embryos were incu-
bated overnight with the primary antibody diluted to
1:100 in PBS-T. Third step: After washing four times, for a
total time of 15 min, in PBS-T, oocytes and embryos were
incubated with avidine for 20 min and then, after further
washing, with the secondary antibody (Biotinylated Anti-
Rabbit IgG made in goat: D.B.A. Vector, UK; BA-1000) for
4 hours at 4°C and with Rhodamine Avidin D, TMRITC
(D.B.A. Vector, UK; A-2002) for 3 hours. Rhodamine pro-
vided a second label to FITC. For each experimental trial,
two-three embryos and uncleaved oocytes were used as
minus primary controls. After these steps oocytes and
embryos were stained with 2.5 μg/mL Hoechst 33258
(Sigma 1155) in 3:1 (vol/vol) glycerol/PBS, mounted on
microscope slides, covered with cover slips, sealed with
nail polish and kept at 4°C in the dark until observation.
In order to avoid excess pressure being exerted on the
oocytes/embryos, the coverslides were supported with
thick droplets of a Vaseline-wax mixture placed in each
corner.
To test the specificity of the immunoreactions, histologi-
cal sections of equine subcutaneous fat were used as pos-
itive controls.
Nuclear chromatin evaluation
Oocytes and embryos were evaluated in relation to their
developmental stage under an epifluorescence micro-
scope (Nikon Eclipse 600 equipped with B-2 A (460 nm
excitation/346 nm emission) filter as previously described
[35-37]. Normally cleaved embryos were defined by the
presence of nuclei of regular morphology for each blast-
omere. In the group of uncleaved ova, normal fertilization
was defined by the presence of two polar bodies (PBs)
with two pronuclei (PN). Presence of the metaphase II
(MII) with the 1st PB with the swollen sperm head, a single
PN with signs of the sperm cell in the cytoplasm, tripronu-
cleate zygotes with a single PB extruded, were considered
to represent retarded, arrested or abnormal fertilization,
respectively, and were classified and grouped as abnor-
mally fertilized oocytes. Oocytes with one PN with intact
sperm cell were regarded as activated oocytes. Oocytes
showing MII+PB with an intact sperm cell were classified
as unfertilized. Fertilization rates in these trials included
the oocytes that developed further into embryos as well as
those that were found uncleaved but with evident signs of
fertilization after staining.
Evaluation of leptin and leptin receptor expression by 
confocal microscopy
Oocytes and embryos were observed at 600× magnifica-
tion in oil immersion with a laser scanning confocal
microscope (C1/TE2000-U Nikon). An Argon laser ray at
488 nm and the B-2 A filter (495 nm exposure and 519
nm emission) was used to point out the FITC-conjugated
secondary antibody for Ob-R labelling. A Helium/Neon
laser ray at 543 nm and the G-2 A filter (555 nm exposure
and 580 nm emission) was used to point out the TMRITC-
conjugated secondary antibody for Ob labelling. Scan-
ning was conducted with 25 optical series from the top to
the bottom of the oocyte with a step size of 0.45 μm to
allow three-dimensional distribution analysis. Parameters
related to fluorescence intensity were maintained at con-
stant values for all measurements.
Statistical analysis
The statistical significance of the results was evaluated by
the Chi-square-test with the Yates correction for continu-
ity and by Fisher's exact test. Fisher's exact test was used
when a value of less than 5 was expected in any cell. Pro-
portions of matured, fertilized oocytes and cleaved
embryos after ICSI were compared between each leptin-
treatment group and controls. Values with P < 0.05 were
considered to be statistically significantly different.
Results
Effect of leptin supplementation in IVM medium on 
maturation and fertilization after ICSI
Five consecutive IVM/ICSI trials were performed in the
reproductive season with the aim to evaluate the effects of
leptin supplementation in IVM medium on maturation,
fertilization and developmental potential of equine
oocytes. The ovaries of 60 mares were processed, 503 fol-Reproductive Biology and Endocrinology 2009, 7:113 http://www.rbej.com/content/7/1/113
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licles were scraped and 283 oocytes were recovered (2.4
oocytes/ovary; 57%, n° of recovered oocytes/n° scraped
follicles), 149 surrounded by a Cp cumulus and 134 with
an Exp cumulus. After culture and cumulus removal, 262
oocytes (93%), 137 Cp and 125 Exp, were found as mor-
phologically normal and analyzed for maturation (1st PB
extrusion). Of them, 62 Cp and 77 Exp oocytes were
found matured (total = 139 oocytes), were submitted to
ICSI and allowed to develop in vitro for 72 hours after
sperm injection.
Table 1 shows the maturation and fertilization rates, after
ICSI, of oocytes cultured in presence of leptin in IVM
medium. In Exp oocytes, the maturation rate was signifi-
cantly higher in 100 ng/ml leptin-treated oocytes com-
pared with controls (17/23, 74% vs 17/39, 44%; P <
0.05). In the group of Cp oocytes, the proportion of
matured oocytes did not differ between leptin-treated and
control oocytes. In both groups, Cp or Exp oocytes, there
were no statistically significant differences between
groups with respect to the percentages of normally, abnor-
mally fertilized or activated oocytes. However, the total
(normal + abnormal) fertilization rate was significantly
higher in 10 ng/ml leptin-treated Exp oocytes compared
with controls (9/16, 56% vs 9/39, 23%; percentages of
evaluated oocytes, P < 0.05).
Effects of leptin supplementation in IVM medium on in 
vitro embryo development
Table 2 shows the cleavage rates after ICSI of oocytes cul-
tured in presence of leptin in IVM medium. The addition
of leptin during IVM culture was not effective on embry-
onic development at the 2-4 cell stage. The rates of
embryos which cleaved at the 2-4 cell stage did not statis-
tically differ between leptin treated and control samples
(percentages of the 2-cell stage embryos, NS). However
leptin, added at the concentrations of 100 ng/ml, signifi-
cantly reduced the rates of embryos reaching the 4-8 cell
stage (1/11, 9% vs 10/19, 53%; percentages of the 2-cell
stage embryos, P < 0.05). Whether calculated in respect to
the number of evaluated oocytes, the effects of leptin did
not attain statistical significance.
Embryo quality did not differ between controls and 1, 10
and 1000 ng/ml-treated oocytes. Instead, the exposure to
100 ng/ml significantly increased the rate of embryos,
issuing from Exp oocytes, with grade b of cytoplasmic
fragmentation. In detail, in control oocytes, 9 (82%) out
of the 11 embryos from Cp oocytes and 6 (75%) out of
the 8 embryos from Exp oocytes were categorized as type
a; in the group of oocytes treated with 1 ng/ml, 5 (83%)
out of the 6 Cp embryos and 6 (75%) out of the 8 Exp
embryos were categorized as type a; in oocytes treated
with 10 ng/ml, 4 (57%) out of the 7 Cp embryos and 4
(66%) out of the 6 Exp embryos were categorized as type
a; in oocytes treated with 100 ng/ml, 3 (60%) out of the 5
Cp embryos but none of the 6 Exp embryos were catego-
rized as type a; in oocytes treated with 1000 ng/ml, 3
(60%) out of the 5 Cp embryos and 7 (78%) out of the 9
Exp embryos were categorized as grade a. In all experi-
mental groups, the remaining embryos were of grade c
except a Cp embryo from 100 ng/ml which resulted of
grade d.
Table 1: Dose response effect of leptin on in vitro maturation and fertilization rates of equine oocytes after ICSI















Compact 0 40 17 (43) 11 (28) 0 (0) 11 (28) 0 (0)
1 20 11 (55) 6 (30) 0 (0) 6 (30) 1 (5)
10 26 13 (50) 8 (31) 0 (0) 8 (31) 1 (4)
100 25 9 (36) 5 (20) 1 (4) 6 (24) 1 (4)
1000 26 12 (46) 5 (19) 1 (4) 6 (23) 1 (4)
Expanded 0 39 17 (44)a 9 (23) 0 (0) 9 (23)a 2 (5)
1 23 14 (61) 8 (35) 0 (0) 8 (35) 0 (0)
10 16 12 (75) 8 (50) 1 (6) 9 (56)b 0 (0)
100 23 17 (74)b 7 (30) 2 (9) 9 (39) 1 (4)
1000 24 17 (71) 9 (38) 1 (4) 10 (42) 0 (0)
Total 0 79 34 (43) 20 (25) 0 (0) 20 (25) 2 (3)
1 43 25 (58) 14 (33) 0 (0) 14 (33) 1 (2)
10 42 25 (60) 16 (38) 1 (2) 17 (40) 1 (2)
100 48 26 (54) 12 (25) 3 (6) 15 (31) 2 (4)
1000 50 29 (58) 14 (28) 2 (4) 16 (32) 1 (2)
(*) percentages of the evaluated oocytes
Percentages with different superscripts statistically differ at P < 0.05 (Chi-square-test).Reproductive Biology and Endocrinology 2009, 7:113 http://www.rbej.com/content/7/1/113
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Immunolocalization of Ob and Ob-R in equine early 
embryos
Both leptin ligand and receptor proteins were detected in
embryos obtained from Cp and Exp oocytes. Both pro-
teins were detected at the 2- (Figure 1A1, A2), 4- (Figure
1B1, B2) and 8-cell stage (Figure 1C1, C2) and were over-
lapped and localized in the same area (Figure 1A3, B3,
C3). Figure 2 shows a representative 25 optical planes
analysis of an embryo obtained after IVM culture in pres-
ence of 100 ng/ml leptin. At all analyzed stages, Ob and
Ob-R were present with cortical distribution in each blas-
tomere over the 25 optical planes. Moreover, a granule-
like expression pattern was observed in the cytoplasm of
each blastomere. Leptin receptor staining was positive in
the nuclei of the 4- and 8-cell embryos (Figure 1B1, C1,
D1). The addition of leptin in culture medium did not
modified Ob and Ob-R proteins subcellular localization
in equine early embryos. The same cortical pattern was
evident in mature uncleaved fertilized and unfertilized
oocytes. No immunoreactivities were detected in the neg-
ative controls embryos where primary antibodies were
omitted. Moreover, the reactions of the tissues used as
positive controls gave the expected results (equine subcu-
taneous adipose tissue; data not shown).
Discussion
Our results demonstrated that the addition of leptin in the
range between 10 and 1000 ng/ml increased the matura-
tion rate of equine oocytes even though the statistical sig-
nificance was observed only at the concentration of 100
ng/ml. This result is in line with previous observation in
other species [5-7]. The improvement of maturation rate
of oocytes may be related to some potential action mech-
anisms exerted by leptin on oocyte cytoplasmic matura-
tion. These mechanisms may include direct or indirect
cumulus cell-mediated effects such as restructuring oocyte
cytoskeleton, reprogramming protein synthesis, or inhib-
iting apoptosis [38]. As previously observed in bovine, it
can be hypothesized that leptin may rescue oocytes that
could potentially undergo apoptosis [30]. The beneficial
effect of leptin during oocyte maturation suggests a role
for leptin as a survival factor minimizing cellular damage
to oocyte and/or cumulus cells.
The different response to leptin treatment, observed
between Cp and Exp oocytes, could be due to Ob-R mod-
ifications occurring during the process of cumulus expan-
sion and/or to different expression or activation status of
the receptor in COCs of these two categories. Previous
studies, reporting concentration and stage dependent
effects of leptin on embryonic development may support
our hypothesis [39] and it is possible that Ob-R could acti-
vate in different ways the reported signal-transduction
pathways [8] in Cp and Exp oocytes. Moreover, it has been
suggested that leptin may induce germinal vesicle break-
down (GVBD), in vivo, via its action on the theca cells [9].
On the contrary, in vitro, the effects of leptin on oocyte
maturation may be exerted by a direct action on the
oocyte or indirect effect on cumulus cells. Leptin may
influence the synthesis and release of cumulus cell-
derived factors, which reach the oocyte through gap junc-
tion coupling and the extracellular environment, in differ-
Table 2: Effects of leptin added to IVM medium on equine embryo development








N° (%) of 2 cell 
stage 
embryos**
N° (%) 4 cell 
stage embryos*
N° (%) 8 cell 
stage embryos*
N° (%) 8 cell 
stage 
embryos**
Compact 0 40 11 (28) 10 (91) 5 (45) 5 (13)
1 20 6 (30) 6 (100) 5 (83) 5 (25)
10 26 7 (27) 6 (86) 2 (29) 2 (8)
100 25 5 (20) 5 (100) 0 (0) 0 (0)
1000 26 5 (19) 4 (80) 0 (0) 0 (0)
Expanded 0 39 8 (21) 7 (88) 5 (63) 5 (13)
1 23 8 (35) 8 (100) 5 (63) 5 (22)
10 16 6 (38) 5 (83) 4 (67) 4 (25)
100 23 6 (26) 4 (67) 1 (17) 1 (4)
1000 24 9 (38) 7 (78) 2 (22) 2 (8)
Total 0 79 19 (24) 17 (89) 10 (53)a 10 (13)
1 43 14 (33) 14 (100) 10 (71) 10 (23)
10 42 13 (31) 11 (85) 6 (46) 6 (14)
100 48 11 (23) 9 (82) 1 (9)b 1 (2)
1000 50 14 (28) 11 (79) 2 (14) 2 (4)
(*) percentages of the two cell-stage embryos
(**) percentages of the evaluated oocytes
Different superscripts indicate statistically differences at P < 0.05 (Chi-square-test).Reproductive Biology and Endocrinology 2009, 7:113 http://www.rbej.com/content/7/1/113
Page 7 of 11
(page number not for citation purposes)
Immunocytochemical analysis of Ob and Ob-R proteins expression Figure 1
Immunocytochemical analysis of Ob and Ob-R proteins expression. Representative confocal images of embryos 
obtained by ICSI in oocytes matured in vitro, stained with antibodies directed against Ob-R and Ob protein. For each raw, cor-
responding bright-field (A, B, C, D, E), confocal (A1, B1, C1, D1, E1 for Ob-R; A2, B2, C2, D2, E2 for Ob labeling and A3, B3, 
C3, D3, E3 for Ob-R and Ob merge) and UV light images of blastomere nuclei (A4, B4, C4, D4, E4) of the same embryo are 
shown. After Hoechst 33258 staining, to evaluate chromatin configuration, nuclei of regular morphology in each blastomere 
and residual polar bodies are visible. The 2-cell stage embryo in raw A is representative of embryos issuing from oocytes cul-
tured in presence of 1000 ng/ml leptin; the 4-cell stage embryo in raw B was cultured in presence of 1 ng/ml leptin and the 8-
cell stage embryo in raw C was cultured in presence of 10 ng/ml leptin; the 4-cell stage embryo in raw D was cultured in 
absence of leptin; the 4-cell stage embryo in raw E represents the negative control (no primary antibodies against Ob and Ob-
R). Scale bar represent 60 μm.Reproductive Biology and Endocrinology 2009, 7:113 http://www.rbej.com/content/7/1/113
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Subcellular localization of Ob-R (A) and Ob (B) proteins in an equine IVM/ICSI-derived embryo Figure 2
Subcellular localization of Ob-R (A) and Ob (B) proteins in an equine IVM/ICSI-derived embryo. The sample is 
representative of confocal investigations on 25 serial optical sections (step size = 0.45 μm) performed on all examined 
embryos. A 4-cell stage embryo is shown obtained after IVM culture in presence of 100 ng/ml leptin. In surface planes, in the 
lower (planes n° 1 to 5) and upper (planes n° 19 to 25) parts of the embryo, a labeling in clumps/clusters can be seen while in 
planes nearer the equatorial position (planes n° 6 to 18), an intense fluorescence is observed beneath the oolemma together 
with uniform distribution of Ob (A) and Ob-R (B) staining within the cytoplasm. Scale bar represent 60μm.Reproductive Biology and Endocrinology 2009, 7:113 http://www.rbej.com/content/7/1/113
Page 9 of 11
(page number not for citation purposes)
ent way in Cp or Exp oocytes and, consequently, it can be
hypothesized that Exp cumulus cells could be more
responsive to leptin than Cp cumulus cells [7].
Fertilization rate and embryonic developmental compe-
tence (cleavage and blastocyst rate) are widely used as
indicators of oocyte quality. The enhanced fertilization
rate observed in leptin-treated oocytes confirmed the
stimulatory effect of leptin on oocyte quality. In contrast
with data reported in other species, such as pig [5,6] and
bovine [7], in the present study, leptin had no beneficial
effect on cleavage rates after ICSI but rather, at the concen-
tration of 100 ng/ml, it decreased embryonic develop-
mental rate and increased cytoplasmic fragmentation.
Landt et al. [40] reported that leptin plasma levels differ
between various strains of rats, with variation up to two
times, suggesting that different genetic background can
affect circulating leptin levels. It can, therefore, be sup-
posed that different thresholds may exist in different sub-
jects, cells and tissues, including oocytes and embryos,
with respect to leptin sensitivity, in different species. Few
information is available about intrafollicular leptin con-
centration in differents species. In women with intrafollic-
ular leptin concentrations equal to or higher than 20 ng/
ml, the fertilization rate is significantly higher (85.7%)
than that in women with lower doses (16.7% p < 0.05).
No differences were detected, instead, in the quality of the
embryos obtained either at the zygote stage or 48 hours
after oocyte insemination [41,42]. In pigs, leptin was
detected in follicular fluids pooled from different size fol-
licles as follows: small follicles, 1.21 ± 0.28 ng/ml;
medium follicles, 1.24 ± 0.06 ng/ml; and large follicles,
1.13 ± 0.24 ng/ml and when leptin was added in the mat-
uration medium at the concentration of 10 ng/ml signifi-
cantly increased the proportion of oocytes that reached
the MII stage after 48 h IVM: this concentration should
still be considered as close as possible to physiological lev-
els [5]. To our knowledge, no data on leptin concentration
in the follicular fluid is available in the horse and it could
be possible that the concentration of 100 ng/ml do not
respect the physiological condition. In addition, the Ob/
Ob-R system could significantly differ in the horse com-
pared with humans, non-human primates [43] and other
species. Another possible explanation could be the differ-
ent types of leptin used in various experiments as reported
by Herrid et al. [39]. We used recombinant human leptin
which, by bioinformatic comparison, exhibited high
homology to the leptin of bovine (84%), pig (85%),
equine (82.7%) and mouse (83%). Previously reported
studies [5-7,30] also used recombinant human leptin.
Moreover, caution must be taken when comparing differ-
ent studies due to extensively different culture conditions
dependent on the examined species. Again, our appar-
ently contraddictory results may be due to differences in
semen source (frozen-thawed versus fresh) or fertilization
procedures. In our study, ICSI procedure with fresh semen
in Global medium was previousy tested as a reliable
method to obtain equine embryos [44] whereas in pigs,
Kim et al. [36] and Kun et al. [6] used IVF and Somatic
Cell Nuclear Transfer embryo (SCNT) in NCSU (North
Carolina State University) medium; in bovine, IVF in SOF
(Synthetic Oviductal Fluid) medium was adopted [7].
Our results demonstrated that Ob and Ob-R proteins were
detected in equine ICSI embryos throughout early cleav-
age stages. This finding is in agreement with previous
observation in other species [36]. Moreover, leptin has
been found to be secreted by various reproductive organs
including placenta [45,46] and ovary [47]. Leptin has
been reported to be expressed at high levels in mouse
oocytes at all stages of follicular development whereas low
expression levels were found in the mural granulosa,
stroma, theca, and corpora lutea [3]. Leptin receptor
mRNA and protein were present in the mouse oocytes
[48] and preimplantation embryos [3]. It has been
reported that cultured human blastocysts secrete leptin,
and the levels of leptin are significantly higher than those
of arrested embryos [49]. In human, leptin protein was
localized in immature oocytes and in all stages of embry-
onic development [50,51]. Recently, leptin protein was
reported to be expressed in all stages of porcine IVF
embryos [52]. This finding is also in agreement with our
previous observation in equine oocytes. In oocytes at the
GV stage [29], both Ob and Ob-R were uniformly distrib-
uted throughout the ooplasm, but the intensity of reac-
tion was lower either in light weight mares or in fillies
oocytes, than in oocytes of heavy weight mares. In
matured oocytes, both Ob and Ob-R were localized in the
cortex and concentrated at one pole of the oocyte. This
distribution was indipendent from the animal group and
again with lower intensity in light mares and fillies.
Leptin and Ob-R proteins in equine embryos were distrib-
uted according to the same cortical and cytoplasmic gran-
ule-like distribution pattern in each blastomere.
Interestingly, positive staining was also observed in the
nuclei of 4- and 8-cell stage embryos. This finding is in
agreement with previous observations of nuclear positiv-
ity in neurons in rat brain [53] and perinuclear positivity
in transfected Ob-R expressing HeLa cells [54]. This latter
study [54] examined the intracellular traffic of Ob-R and
reported that both isoforms of Ob-R were observed in
HeLa cells at three cellular localizations, the plasma mem-
brane, the peripheral cytoplasm and the perinuclear com-
partment. The perinuclear staining, localized in the trans
Golgi network area, was reported as probably made of
newly synthetized receptors en route to the cell surface
[54]. The antibody for Ob-R used in the present study
detects both short and long forms of Ob-R [55]. Thus, it is
not known which Ob-R isoform mediated the effect ofReproductive Biology and Endocrinology 2009, 7:113 http://www.rbej.com/content/7/1/113
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leptin on equine oocytes during IVM and is expressed in
equine embryos.
Conclusion
The present study demonstrated for the first time that, in
the horse, the addition of leptin during IVM, in the range
between 10 and 1000 ng/ml, has a beneficial effect on
meiotic maturation and fertilization after ICSI but it
impairs embryonic development. In addition, it was dem-
onstrated that Ob and Ob-R proteins are expressed in
equine early embryos. The presence of both ligand and
receptor proteins in oocytes [29] and in ICSI embryos sug-
gests that leptin acts as an autocrine/paracrine hormone
in horse maturation, fertilization and early development.
Species-specific differences may exist in oocytes/embryos
with regard to the sensitivity to leptin.
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